Stay updated on REGN3500 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error page with a Home button, replacing the previous study details content. This indicates restricted access to the study record.SummaryDifference19%

- Check9 days agoChange DetectedAdds a new site revision tag: v3.7.0, replacing the previous v3.6.6. This indicates a minor release or update to the page infrastructure without altering the study details or visible content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates an updated page revision without changes to the study information.SummaryDifference0.0%

- Check30 days agoChange DetectedA new funding/ID entry, '2018 ( U.S. NIH Grant/Contract )', was added to the study's identifiers, indicating NIH support for the trial. This expands the funding context shown on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an internal page version update with no visible content changes.SummaryDifference0.0%

- Check58 days agoChange DetectedPublications section added with a PubMed-cited article on itepekimab pharmacokinetics/pharmacodynamics and a note that publications are automatically filled from PubMed.SummaryDifference0.2%

Stay in the know with updates to REGN3500 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 in Atopic Dermatitis Clinical Trial page.